Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Moodys
Medtronic
Daiichi Sankyo
UBS
Federal Trade Commission
Merck
Fuji

Generated: April 20, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: micafungin sodium

« Back to Dashboard

micafungin sodium

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astellas MYCAMINE micafungin sodium INJECTABLE;IV (INFUSION) 021506 NDA Astellas Pharma US, Inc. N 0469-3211-10
Astellas MYCAMINE micafungin sodium INJECTABLE;IV (INFUSION) 021506 NDA Astellas Pharma US, Inc. N 0469-3211-99
Astellas MYCAMINE micafungin sodium INJECTABLE;IV (INFUSION) 021506 NDA Astellas Pharma US, Inc. N 0469-3250-10
Astellas MYCAMINE micafungin sodium INJECTABLE;IV (INFUSION) 021506 NDA Astellas Pharma US, Inc. N 0469-3250-50
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chinese Patent Office
QuintilesIMS
Dow
US Army
Farmers Insurance
Merck
Accenture
Harvard Business School